BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29989647)

  • 21. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.
    Serafim Junior V; Fernandes GMM; Oliveira-Cucolo JG; Pavarino EC; Goloni-Bertollo EM
    Cytokine; 2020 Dec; 136():155270. PubMed ID: 32911446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
    Oyama Y; Nagao S; Na L; Yanai K; Umebayashi M; Nakamura K; Nagai S; Fujimura A; Yamasaki A; Nakayama K; Morisaki T; Onishi H
    Anticancer Res; 2021 Aug; 41(8):4047-4052. PubMed ID: 34281873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibition of BDNF/TrkB/PI3K/Akt signal mediated by AG1601 promotes apoptosis in malignant glioma.
    Yin H; Jiang Y; Zhang Y; Ge H; Yang Z
    J Cell Biochem; 2019 Nov; 120(11):18771-18781. PubMed ID: 31219215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
    Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
    Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.
    Xu Y; Jiang WG; Wang HC; Martin T; Zeng YX; Zhang J; Qi YS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.
    Okugawa Y; Tanaka K; Inoue Y; Kawamura M; Kawamoto A; Hiro J; Saigusa S; Toiyama Y; Ohi M; Uchida K; Mohri Y; Kusunoki M
    Br J Cancer; 2013 Jan; 108(1):121-30. PubMed ID: 23175149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
    Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
    PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA‑155 contributes to the occurrence of epilepsy through the PI3K/Akt/mTOR signaling pathway.
    Duan W; Chen Y; Wang XR
    Int J Mol Med; 2018 Sep; 42(3):1577-1584. PubMed ID: 29901097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases.
    Choy C; Ansari KI; Neman J; Hsu S; Duenas MJ; Li H; Vaidehi N; Jandial R
    Breast Cancer Res; 2017 Apr; 19(1):51. PubMed ID: 28446206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/Akt signaling pathway in stroke.
    Qi D; Ouyang C; Wang Y; Zhang S; Ma X; Song Y; Yu H; Tang J; Fu W; Sheng L; Yang L; Wang M; Zhang W; Miao L; Li T; Huang X; Dong H
    Brain Res; 2014 Aug; 1577():69-76. PubMed ID: 24997248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma.
    Jia S; Wang W; Hu Z; Shan C; Wang L; Wu B; Yang Z; Yang X; Lei D
    Oral Oncol; 2015 Jan; 51(1):64-70. PubMed ID: 25456007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BDNF/TrkB/Akt Signaling Pathway Epithelial Odontogenic Tumors and Keratocyst: An Immunohistochemical Study Comparative With Dental Germs.
    Dornelles FML; Wagner VP; Fonseca FP; Ariotti C; Carrard VC; Vargas PA; Sánchez-Romero C; Beovide V; Bologna-Molina R; Martins MD
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):366-373. PubMed ID: 32941187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor improves proliferation of endometrial epithelial cells by inhibition of endoplasmic reticulum stress during early pregnancy.
    Lim W; Bae H; Bazer FW; Song G
    J Cell Physiol; 2017 Dec; 232(12):3641-3651. PubMed ID: 28150859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macranthol promotes hippocampal neuronal proliferation in mice via BDNF-TrkB-PI3K/Akt signaling pathway.
    Luo L; Liu XL; Li J; Mu RH; Liu Q; Yi LT; Geng D
    Eur J Pharmacol; 2015 Sep; 762():357-63. PubMed ID: 26004527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound Enhances the Expression of Brain-Derived Neurotrophic Factor in Astrocyte Through Activation of TrkB-Akt and Calcium-CaMK Signaling Pathways.
    Liu SH; Lai YL; Chen BL; Yang FY
    Cereb Cortex; 2017 Jun; 27(6):3152-3160. PubMed ID: 27252349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
    Li Y; Cui N; Zheng PS; Yang WT
    Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
    Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
    APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.
    Odate S; Nakamura K; Onishi H; Kojima M; Uchiyama A; Nakano K; Kato M; Tanaka M; Katano M
    Lung Cancer; 2013 Mar; 79(3):205-14. PubMed ID: 23312550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.
    Moraes JK; Wagner VP; Fonseca FP; Amaral-Silva GKD; de Farias CB; Pilar EFS; Gregianin L; Roesler R; Vargas PA; Martins MD
    Oral Dis; 2019 Nov; 25(8):1925-1936. PubMed ID: 31498938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.